1. Home
  2. Programs
  3. Focus on Public Health Policy

ADHD Meets Public Policy

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
  • Overview

    Pediatric attention deficit hyperactivity disorder (ADHD) is a controversial diagnosis and everybody has an opinion on medications like Ritalin. Dr. Rick Mayes, associate professor of public policy at the University of Richmond's department of political science and a faculty research fellow at the Petris Center on Healthcare Markets and Consumer Welfare at University of California, Berkeley, reminds us that this ongoing dialogue doesn't really reflect the scientific validity of ADHD and its treatment, but rather gives us a window into what happens when science is translated into public policy, rules and even the law. Dr. Leslie Lundt hosts.

Recommended
Details
Presenters
  • Overview

    Pediatric attention deficit hyperactivity disorder (ADHD) is a controversial diagnosis and everybody has an opinion on medications like Ritalin. Dr. Rick Mayes, associate professor of public policy at the University of Richmond's department of political science and a faculty research fellow at the Petris Center on Healthcare Markets and Consumer Welfare at University of California, Berkeley, reminds us that this ongoing dialogue doesn't really reflect the scientific validity of ADHD and its treatment, but rather gives us a window into what happens when science is translated into public policy, rules and even the law. Dr. Leslie Lundt hosts.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free